Referred to the House Committee on Energy and Commerce.
This resolution is a nonbinding statement by the House expressing its views and priorities about federal biomedical research. It does not create law, change agency rules, or directly provide funding; instead it declares the House's policy preferences—such as protecting and expanding NIH-led research, insulating scientific decisionmaking from political interference, and calling for a doubling of federal biomedical research investment over the next decade. It is meant to guide lawmakers, inform the public, and signal priorities to federal agencies and future legislation.
This House resolution expresses the sense of the House that the federal government should lead the world in biomedical research, praises the historical role and achievements of the National Institutes of Health (NIH), and identifies priorities for federal biomedical research (basic science, translational work, workforce, equity in trials, high-risk/high-reward projects, and integration of findings into practice).
The text cites specific public-health successes attributed to federally supported research and economic-return estimates from past programs, and it criticizes actions taken by the Trump administration as having undermined U.S. biomedical research capacity.
The resolution calls for insulating scientific decisionmaking from political interference and states that the federal government should double its investment in biomedical research over the next decade.
As a House sense resolution it does not create law or authorize funding; therefore the intrinsic probability of it 'becoming law' is effectively negligible. Its primary effect would be political messaging. The content could inform or motivate subsequent substantive legislation (e.g., appropriations or authorization bills to increase NIH funding), but passage of those follow‑on measures would depend on separate, more difficult negotiations and fiscal choices.
Relative to its intended legislative type, this bill functions as a nonbinding expression of congressional priorities that clearly frames the problem and states broad policy preferences but lacks the legislative mechanisms, funding details, implementation instructions, and accountability measures needed to effectuate the ambitions it articulates.
Size and pace of increased federal funding: liberals strongly favor the ‘double NIH over a decade’ goal, centrists want phased/costed plans, conservatives object to unfunded increases.
These are examples from the analysis, not a ranked list of the most-affected groups.
Size and pace of increased federal funding: liberals strongly favor the ‘double NIH over a decade’ goal, centrists want phased/costed plans, conservatives object to unfunded increases.
A mainstream liberal would view the resolution positively as a strong reaffirmation of the federal government's role in supporting science and public health.
They would welcome the emphasis on NIH, on protecting scientists from political interference, on equity in research participation, and on increasing funding for basic and high‑risk research that the private sector may not support.
They would also view the resolution's explicit criticism of the Trump administration’s actions as justified context for why stronger protections and investments are needed.
A centrist would generally support the resolution’s goals — protecting NIH, promoting science driven by peer review, and investing in biomedical research — but would be cautious about the political framing and the open-ended call to double funding.
They would appreciate the historical rationale and public‑health priorities but want clarity on costs, timelines, and metrics.
Centrists would also be sensitive to the resolution’s partisan language criticizing a prior administration because it may hinder bipartisan implementation of the declared objectives.
A mainstream conservative would be skeptical of parts of the resolution: they are likely to support the general idea of federal involvement in foundational research that serves national interests but oppose the resolution’s partisan language and its broad call to double federal spending without identified offsets.
They would also be cautious about expanding federal control or creating expectations of large, ongoing appropriations and may dispute some of the resolution’s factual assertions about the prior administration’s actions.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a House sense resolution it does not create law or authorize funding; therefore the intrinsic probability of it 'becoming law' is effectively negligible. Its primary effect would be political messaging. The content could inform or motivate subsequent substantive legislation (e.g., appropriations or authorization bills to increase NIH funding), but passage of those follow‑on measures would depend on separate, more difficult negotiations and fiscal choices.
The bill has not accumulated any surfaced votes yet.
Size and pace of increased federal funding: liberals strongly favor the ‘double NIH over a decade’ goal, centrists want phased/costed plans…
As a House sense resolution it does not create law or authorize funding; therefore the intrinsic probability of it 'becoming law' is effect…
Relative to its intended legislative type, this bill functions as a nonbinding expression of congressional priorities that clearly frames the problem and states broad policy preferences but lacks the legislative mechani…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.